Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;334:1071 (26 May), doi:10.1136/bmj.39220.443889.3A
| The first 150 words of the full text of this article appear below. |
Planning for triage of scarce resources in the face of a flu pandemic is not simply an abstract moral dilemma1: it remains unsolved at the highest levels of international planning. Europe remains two to three years away from a state of preparedness for a flu pandemic.2 Previous modelling has shown that a massive and focused use of antivirals and vaccines in places where flu may originateprobably developing countriesis vital to mitigating a pandemic.3 This strategy presupposes that available limited resources will be distributed fairly in developing countries. This presumption is currently unrealistic.
A recent analysis of pandemic preparedness plans worldwide noted three goals of pharmaceutical interventions: reduction of morbidity and mortality (21 plans), continued maintenance of essential services (13 plans), and minimisation of social and economic impacts (13 plans).4 The overarching goal for the early pandemic phases in the World Health Organization's plan is to coordinate maximum international efforts
Daniel J Barnett, instructor1, Saad B Omer, assistant scientist1, David P Fidler, professor of law2, Ran D Balicer, researcher3, James G Hodge, Jr, associate professor4
1 Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA, 2 Indiana University School of Law, Bloomington, IN 47405, USA, 3 Ben-Gurion University of the Negev, Ramat-Gan, Israel 52394, 4 Johns Hopkins Bloomberg School of Public Health
dbarnett@jhsph.edu